secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K/A
Filed at:   2026-01-16T23:59:59+00:00
Accession:  0001213900-26-005165
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma completes $2.28M additional unregistered offering, issues 1.5M shares
--------------------------------------------------------------------------------

- From May 26, 2025 to Jan 6, 2026, ABVC accepted additional subscriptions totaling $2,275,468 under same terms as prior Reg S offering.
- Issued 1,500,250 shares of common stock at prices ranging from $1.00 to $1.95 per share.
- Shares represent approximately 5.92% of outstanding common stock as of filing date.
- All purchasers are non-U.S. persons (accredited investors); voting rights transferred to Chairman Eugene Jiang via proxy agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390026005165/0001213900-26-005165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390026005165/ea0272768-8ka1_abvc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-005165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer